These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 25044451)

  • 1. The microbiome in early life: self-completion and microbiota protection as health priorities.
    Dietert RR
    Birth Defects Res B Dev Reprod Toxicol; 2014 Aug; 101(4):333-40. PubMed ID: 25044451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The developing intestinal microbiome: probiotics and prebiotics.
    Neu J
    World Rev Nutr Diet; 2014; 110():167-76. PubMed ID: 24751628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The gut microbiota and inflammatory noncommunicable diseases: associations and potentials for gut microbiota therapies.
    West CE; Renz H; Jenmalm MC; Kozyrskyj AL; Allen KJ; Vuillermin P; Prescott SL;
    J Allergy Clin Immunol; 2015 Jan; 135(1):3-13; quiz 14. PubMed ID: 25567038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'The way to a man's heart is through his gut microbiota'--dietary pro- and prebiotics for the management of cardiovascular risk.
    Tuohy KM; Fava F; Viola R
    Proc Nutr Soc; 2014 May; 73(2):172-85. PubMed ID: 24495527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbial therapeutic interventions.
    Grady NG; Petrof EO; Claud EC
    Semin Fetal Neonatal Med; 2016 Dec; 21(6):418-423. PubMed ID: 27133778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbiota abnormalities in inflammatory airway diseases - Potential for therapy.
    Gollwitzer ES; Marsland BJ
    Pharmacol Ther; 2014 Jan; 141(1):32-9. PubMed ID: 23969226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prebiotics and probiotics: their role in the management of gastrointestinal disorders in adults.
    Quigley EM
    Nutr Clin Pract; 2012 Apr; 27(2):195-200. PubMed ID: 22127952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Data mining the human gut microbiota for therapeutic targets.
    Collison M; Hirt RP; Wipat A; Nakjang S; Sanseau P; Brown JR
    Brief Bioinform; 2012 Nov; 13(6):751-68. PubMed ID: 22445903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probiotics and prebiotics and health in ageing populations.
    Duncan SH; Flint HJ
    Maturitas; 2013 May; 75(1):44-50. PubMed ID: 23489554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probiotic strategies for treatment of respiratory diseases.
    Nagalingam NA; Cope EK; Lynch SV
    Trends Microbiol; 2013 Sep; 21(9):485-92. PubMed ID: 23707554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota and allergic disease: new findings.
    West CE
    Curr Opin Clin Nutr Metab Care; 2014 May; 17(3):261-6. PubMed ID: 24535216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiome in parturition and preterm birth.
    Mysorekar IU; Cao B
    Semin Reprod Med; 2014 Jan; 32(1):50-5. PubMed ID: 24390921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the microbiota in the management of gastrointestinal and liver disease.
    Quigley EM; Monsour HP
    Rev Gastroenterol Peru; 2013; 33(2):139-44. PubMed ID: 23838941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering Human Microbiota: Influencing Cellular and Community Dynamics for Therapeutic Applications.
    Woloszynek S; Pastor S; Mell JC; Nandi N; Sokhansanj B; Rosen GL
    Int Rev Cell Mol Biol; 2016; 324():67-124. PubMed ID: 27017007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of altered intestinal microbiota in systemic inflammation and cardiovascular disease in chronic kidney disease.
    Mafra D; Lobo JC; Barros AF; Koppe L; Vaziri ND; Fouque D
    Future Microbiol; 2014; 9(3):399-410. PubMed ID: 24762311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of prebiotics and probiotics on skin health.
    Al-Ghazzewi FH; Tester RF
    Benef Microbes; 2014 Jun; 5(2):99-107. PubMed ID: 24583611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the intestinal microbiota in the pediatric population: a clinical perspective.
    Ringel-Kulka T
    Nutr Clin Pract; 2012 Apr; 27(2):226-34. PubMed ID: 22402406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diverse microbial exposure - consequences for vaccine development.
    Björkstén B
    Vaccine; 2012 Jun; 30(29):4336-40. PubMed ID: 22079075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of the development of the intestinal microbiota in infancy.
    Vael C; Desager K
    Curr Opin Pediatr; 2009 Dec; 21(6):794-800. PubMed ID: 19770768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Programming infant gut microbiota: influence of dietary and environmental factors.
    Marques TM; Wall R; Ross RP; Fitzgerald GF; Ryan CA; Stanton C
    Curr Opin Biotechnol; 2010 Apr; 21(2):149-56. PubMed ID: 20434324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.